RPbio Transitions to Single CEO as Co-CEO Kim Hyun-sun Resigns
RPbio announced that co-CEO Kim Hyun-sun resigned due to personal reasons, transitioning to a single CEO structure led by Yoon Jae-hoon effective June 30, 2026.
Former co-CEO Kim resigned from both CEO and inside director positions, while current CEO Yoon retains his role as largest shareholder with a 48.27% stake.
This change is a governance adjustment with no associated capital events or fundraising activities.
[AI Summary]RPbio's shift from co-CEO to single CEO structure, combined with the high ownership stake of the remaining CEO Yoon Jae-hoon, suggests management stability is likely maintained. Investors should monitor any future strategic shifts.